TKPHF
Takeda Pharmaceutical Company
Exchange: PINK
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, sale, and import/export of pharmaceutical drugs worldwide. It provides products in various therapeutic areas, including cardiovascular and metabolic, respiratory and immunology, oncology, central nervous system, general medicine, vaccines, and consumer healthcare drugs and quasi-drugs. The company has strategic partnership with BioMotiv, LLC; and a collaboration agreement with Mersana Therapeutics Inc. and Queen Mary University of London. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.
Current Price
$32.26
+0.00%Profile
Valuation (TTM)
Market Cap—
P/E—
EV—
P/B—
Shares Out—
P/Sales—
Revenue—
EV/EBITDA—
Takeda Pharmaceutical Company (TKPHF) Stock News
TKPHF Stock News & Headlines
Latest stock news and headlines for Takeda Pharmaceutical Company (TKPHF). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $32.26. This page aggregates the latest news articles relevant to TKPHF from financial news sources, helping investors stay current on events that may impact Takeda Pharmaceutical Company's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Takeda Pharmaceutical Company (TKPHF).